Related Experiment Videos
[C-reactive protein in cardiovascular risk evaluation].
Damir Fabijanić1, Marko Banić, Dusko Kardum
1Klinika za unutarnje bolesti Klinicke bolnice Split, lokalitet Kriline, Split. damir.fabijanic@st.t-com.hr
Lijecnicki Vjesnik
|August 17, 2006
Summary
High-sensitive C-reactive protein (hs-CRP) indicates elevated cardiovascular risk and helps monitor treatment effectiveness. Elevated hs-CRP levels signal increased risk for cardiovascular events and guide preventive therapies.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Research
Context:
- Atherosclerosis involves inflammation, impacting cardiovascular risk.
- Global cardiovascular risk assessment necessitates reliable inflammatory markers.
- High-sensitive C-reactive protein (hs-CRP) is a key inflammatory marker.
Purpose:
- To review the role of hs-CRP in atherosclerosis pathogenesis.
- To discuss the clinical applications of hs-CRP in cardiovascular disease.
- To evaluate hs-CRP for risk stratification and therapeutic monitoring.
Summary:
- hs-CRP levels above 3 mg/L identify increased risk for cardiovascular events in diverse patient groups.
- Pharmacological and lifestyle interventions that reduce cardiovascular events also lower hs-CRP.
- hs-CRP aids in identifying high-risk individuals, monitoring disease activity, and assessing treatment efficacy.
Impact:
- hs-CRP serves as a valuable tool for primary and secondary cardiovascular prevention strategies.
- Understanding hs-CRP's role enhances clinical practice in managing atherosclerosis.
- hs-CRP levels can guide targeted therapeutic interventions for cardiovascular health.